+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Forecast 2024-2030- Product Image
Global Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Forecast 2024-2030- Product Image
Sale

Global Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829828
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Vaccines Market size was estimated at USD 9.82 billion in 2023, USD 10.40 billion in 2024, and is expected to grow at a CAGR of 6.43% to reach USD 15.19 billion by 2030.

Veterinary vaccines are biologically prepared substances that stimulate an animal's immune system to protect it from specific diseases. These vaccines function similarly to human vaccines by introducing antigens, typically inactivated or attenuated forms of pathogens or their components, into the animal's body. This exposure triggers an immune response, including producing antibodies, memory cells, and other defense mechanisms, so the animal can develop immunity to the targeted disease without getting sick. Increasing pet adoption, livestock population, rising awareness of zoonotic diseases, surging incidences of animal diseases, and escalating investments in animal health drive further growth. However, the high cost of vaccine storage and difficulties in maintaining the viability of vaccines during transport pose significant issues in the market expansion. The increasing count of in-house pets escalated the focus on food safety, and advancements in biotechnological research provide significant opportunities in the market.

Regional Insights

The Americas exhibits the highest adoption of veterinary vaccines, primarily due to the high animal population and increasing awareness of animal health. Various regulations and guidelines set by local animal health organizations have substantially driven vaccine adoption. In EMEA, Europe leads in adopting veterinary vaccines owing to the region's advanced medical and technological infrastructure, robust regulatory frameworks, and initiatives promoting animal welfare, significantly contributing to this growth. In the Middle East and Africa, increasing investments and efforts towards improving animal health care systems signify growth potential. APAC, home to a large livestock population and high pet ownership, presents significant potential for veterinary vaccine adoption. Rapid urbanization and increasing pet adoption rates facilitate market expansion alongside governmental directives on disease prevention. The APAC Countries have been increasingly focusing on animal health as urban areas report high vaccine adoption due to increasing companion animal ownership and awareness.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Veterinary Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Veterinary Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Vaccines Market, highlighting leading vendors and their innovative profiles. These include Addison Biological Laboratory Inc., Aptimmune Biologics, Inc, Bimeda Inc., Biokema SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Santé Animale, China Animal Husbandry Industry Co., Ltd, Covetrus, Inc., Elanco Animal Health Incorporated, Endovac Animal Health., Hester Biosciences Limited, HIPRA, S.A, Indian Immunologicals Ltd., Kemin Industries, Inc., Kyoritsuseiyaku Corporation, Laboratoire LCV, Meiji Holdings Co., Ltd., Merck & Co., Inc, Neogen Corporation, Norbrook Laboratories Limited, Phibro Animal Health Corporation, Saiba Animal Health AG, Sumitomo Pharma Animal Health Co., Ltd., Torigen Pharmaceuticals Inc., Vaxxinova International BV, Virbac SA, YEBIO BIOENGINEERING CO., LTD OF QINGDAO, and Zoetis Inc.

Market Segmentation & Coverage

This research report categorizes the Veterinary Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Animal Type
    • Aquaculture
    • Companion Animals
    • Livestock
      • Bovine
      • Porcine
      • Poultry
      • Small Ruminants
  • Technology
    • Inactivated Vaccines
    • Live Attenuated Vaccines
    • Recombinant Vaccines
    • Toxoid Vaccines
  • Route of Administration
    • Intravenous
    • Nasal
    • Oral
  • Distribution Channel
    • Hospitals & Clinics
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Veterinary Vaccines Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Veterinary Vaccines Market?
  3. What are the technology trends and regulatory frameworks in the Veterinary Vaccines Market?
  4. What is the market share of the leading vendors in the Veterinary Vaccines Market?
  5. Which modes and strategic moves are suitable for entering the Veterinary Vaccines Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Veterinary Vaccines Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of companion animal and livestock ownership
5.1.1.2. Rising incidence of chronic diseases and accidental injuries in animals
5.1.1.3. Government initiatives for immunization of veterinary animals
5.1.2. Restraints
5.1.2.1. High cost associated with development, storage, and handling of vaccines
5.1.3. Opportunities
5.1.3.1. Shift from live attenuated vaccines to DNA vaccines
5.1.3.2. Rising investments and R&D for development of novel veterinary vaccines
5.1.4. Challenges
5.1.4.1. Concerns associated with stringent regulatory compliance
5.2. Market Segmentation Analysis
5.2.1. Animal Type: Rising usage of vaccines for disease prevention in livestock animals
5.2.2. Technology: Increasing use of inactivated sensors to reduce the burden of target diseases such as rabies, influenza, and leptospirosis
5.2.3. Route of Administration: Growing preference for nasal administration owing to its user-friendly and non-invasive nature
5.2.4. Distribution Channel: Rising accessibility of vaccines across veterinary hospitals & clinics
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Veterinary Vaccines Market, by Animal Type
6.1. Introduction
6.2. Aquaculture
6.3. Companion Animals
6.4. Livestock
6.5.1. Bovine
6.5.2. Porcine
6.5.3. Poultry
6.5.4. Small Ruminants
7. Veterinary Vaccines Market, by Technology
7.1. Introduction
7.2. Inactivated Vaccines
7.3. Live Attenuated Vaccines
7.4. Recombinant Vaccines
7.5. Toxoid Vaccines
8. Veterinary Vaccines Market, by Route of Administration
8.1. Introduction
8.2. Intravenous
8.3. Nasal
8.4. Oral
9. Veterinary Vaccines Market, by Distribution Channel
9.1. Introduction
9.2. Hospitals & Clinics
9.3. Retail Pharmacies
10. Americas Veterinary Vaccines Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Veterinary Vaccines Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Veterinary Vaccines Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Merck Animal Health to Acquire Venc
13.3.2. New Product Launch & Enhancement
13.3.2.1. Merck Animal Health launches 3-in-one swine vaccine
13.3.3. Investment & Funding
13.3.3.1. IIL to set up new animal vaccine unit in Hyderabad, India at INR 700 crore
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Addison Biological Laboratory Inc.
14.1.2. Aptimmune Biologics, Inc
14.1.3. Bimeda Inc.
14.1.4. Biokema SA
14.1.5. Boehringer Ingelheim International GmbH
14.1.6. Brilliant Bio Pharma Private Limited
14.1.7. Ceva Santé Animale
14.1.8. China Animal Husbandry Industry Co., Ltd
14.1.9. Covetrus, Inc.
14.1.10. Elanco Animal Health Incorporated
14.1.11. Endovac Animal Health.
14.1.12. Hester Biosciences Limited
14.1.13. HIPRA, S.A
14.1.14. Indian Immunologicals Ltd.
14.1.15. Kemin Industries, Inc.
14.1.16. Kyoritsuseiyaku Corporation
14.1.17. Laboratoire LCV
14.1.18. Meiji Holdings Co., Ltd.
14.1.19. Merck & Co., Inc
14.1.20. Neogen Corporation
14.1.21. Norbrook Laboratories Limited
14.1.22. Phibro Animal Health Corporation
14.1.23. Saiba Animal Health AG
14.1.24. Sumitomo Pharma Animal Health Co., Ltd.
14.1.25. Torigen Pharmaceuticals Inc.
14.1.26. Vaxxinova International BV
14.1.27. Virbac SA
14.1.28. YEBIO BIOENGINEERING CO., LTD OF QINGDAO
14.1.29. Zoetis Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. VETERINARY VACCINES MARKET RESEARCH PROCESS
FIGURE 2. VETERINARY VACCINES MARKET SIZE, 2022 VS 2030
FIGURE 3. VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VETERINARY VACCINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. VETERINARY VACCINES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. VETERINARY VACCINES MARKET DYNAMICS
FIGURE 7. VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2022 VS 2030 (%)
FIGURE 8. VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 10. VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 12. VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 14. VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. VETERINARY VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. VETERINARY VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 6. VETERINARY VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VETERINARY VACCINES MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 10. VETERINARY VACCINES MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VETERINARY VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. VETERINARY VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VETERINARY VACCINES MARKET SIZE, BY SMALL RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 15. VETERINARY VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VETERINARY VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VETERINARY VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. VETERINARY VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 20. VETERINARY VACCINES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. VETERINARY VACCINES MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. VETERINARY VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. VETERINARY VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. VETERINARY VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. CANADA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 44. CANADA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. CANADA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. MEXICO VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 49. MEXICO VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. MEXICO VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. CHINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 70. CHINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 71. CHINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. CHINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. CHINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. INDIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 76. INDIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. INDIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. INDIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. JAPAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 85. JAPAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 86. JAPAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. JAPAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. JAPAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. THAILAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 116. THAILAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. THAILAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. THAILAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 132. DENMARK VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. EGYPT VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 137. EGYPT VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. EGYPT VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. FINLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 141. FINLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 142. FINLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. FINLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. FRANCE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 147. FRANCE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. FRANCE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. GERMANY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 152. GERMANY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. GERMANY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. ITALY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 162. ITALY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. ITALY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. NORWAY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 176. NORWAY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 177. NORWAY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. NORWAY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. NORWAY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. POLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 181. POLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 182. POLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. POLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. POLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. QATAR VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 187. QATAR VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. QATAR VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. SPAIN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 207. SPAIN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. SPAIN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. TURKEY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 222. TURKEY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. TURKEY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. VETERINARY VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 236. VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 237. VETERINARY VACCINES MARKET LICENSE & PRICING

Companies Mentioned

  • Addison Biological Laboratory Inc.
  • Aptimmune Biologics, Inc
  • Bimeda Inc.
  • Biokema SA
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • Ceva Santé Animale
  • China Animal Husbandry Industry Co., Ltd
  • Covetrus, Inc.
  • Elanco Animal Health Incorporated
  • Endovac Animal Health.
  • Hester Biosciences Limited
  • HIPRA, S.A
  • Indian Immunologicals Ltd.
  • Kemin Industries, Inc.
  • Kyoritsuseiyaku Corporation
  • Laboratoire LCV
  • Meiji Holdings Co., Ltd.
  • Merck & Co., Inc
  • Neogen Corporation
  • Norbrook Laboratories Limited
  • Phibro Animal Health Corporation
  • Saiba Animal Health AG
  • Sumitomo Pharma Animal Health Co., Ltd.
  • Torigen Pharmaceuticals Inc.
  • Vaxxinova International BV
  • Virbac SA
  • YEBIO BIOENGINEERING CO., LTD OF QINGDAO
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 10.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 15.19 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Global Veterinary Pharmaceuticals Market by Product (Veterinary Antibiotics, Veterinary Parasiticides, Veterinary Vaccines), Vaccines (Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), Antibiotics, End User, Animal - Forecast 2024-2030 - Product Image

Global Veterinary Pharmaceuticals Market by Product (Veterinary Antibiotics, Veterinary Parasiticides, Veterinary Vaccines), Vaccines (Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), Antibiotics, End User, Animal - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Veterinary Vaccines: Global Markets - Product Image

Veterinary Vaccines: Global Markets

  • Report
  • 313 Pages
  • Global
From
Global Veterinary Vaccines Market Analysis & Forecast 2024-2034: Market By Product; By Animal; By Route of Administration; and By Region - Product Image

Global Veterinary Vaccines Market Analysis & Forecast 2024-2034: Market By Product; By Animal; By Route of Administration; and By Region

  • Report
  • 145 Pages
  • Global
From
Veterinary Vaccine Market - A Global and Regional Analysis: Focus on Type, Disease, Technology, Route of Administration, Distribution Channel, and Region - Analysis and Forecast, 2023-2033 - Product Image

Veterinary Vaccine Market - A Global and Regional Analysis: Focus on Type, Disease, Technology, Route of Administration, Distribution Channel, and Region - Analysis and Forecast, 2023-2033

  • Report
  • 165 Pages
  • Global
From
Veterinary Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Veterinary Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 139 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.